Logotype for Biosyent Inc

Biosyent (RX) investor relations material

Biosyent Q2 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Biosyent Inc
Q2 2025 earnings summary21 Aug, 2025

Executive summary

  • Achieved record quarterly and first-half sales, with Q2 2025 revenue up 14% year-over-year and H1 2025 up 27% year-over-year, driven by all business segments and strong product performance.

  • EBITDA and net income after tax (NIAT) grew 35% and 28% in Q2, and 40% and 30% in H1, respectively, compared to prior year periods.

  • Sixtieth consecutive profitable quarter achieved, with profitability dating back to 2010 and fully diluted EPS reaching $0.72 for Q2 2025 TTM.

  • Expanded product portfolio and global reach, including first Tibelia® Global shipments and continued FeraMAX® leadership.

  • All business segments—Canadian, international, and legacy—contributed to growth, with international sales surging 183% in Q2 2025.

Financial highlights

  • Q2 2025 sales: $10.18M (+14% YoY); H1 2025 sales: $21.16M (+27% YoY).

  • Q2 2025 EBITDA: $2.76M (+35% YoY); H1 2025 EBITDA: $5.96M (+40% YoY).

  • Q2 2025 NIAT: $2.02M (+28% YoY); H1 2025 NIAT: $4.34M (+30% YoY).

  • EBITDA and NIAT margins for the quarter were 27% and 20%, respectively; H1 2025 margins were 28% and 21%.

  • Gross profit for H1 2025 was $16.25M (+23% YoY); operating expenses for H1 2025 increased 20% YoY to $10.35M.

Outlook and guidance

  • Strong business momentum is expected to continue through the latter part of the third quarter and beyond, with further Tibelia® Global shipments planned for H2 2025.

  • Continued innovation and expansion of FeraMAX® product line, with new Fairmax product launch planned for 2026.

  • Management remains committed to long-term value creation through portfolio diversification and profitable growth.

  • No material impact anticipated from tariffs or trade uncertainty for the remainder of the year.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Biosyent earnings date

Logotype for Biosyent Inc
Q3 202519 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Biosyent earnings date

Logotype for Biosyent Inc
Q3 202519 Nov, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

BioSyent Inc., a specialty pharmaceutical company, sources, acquires or in-licenses, develops, and sells pharmaceutical and other healthcare products in Canada. It focuses on the acquisition of oncology drugs, medical devices and other healthcare products. BioSyent Inc. is based in Mississauga, Canada.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage